Journal of the American Society of Nephrology, Vol 5, 1349-1354, Copyright © 1994 by American Society of Nephrology

REGULAR ARTICLES

Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease

AB Chapman, AM Johnson, PA Gabow and RW Schrier
University of Colorado Health Sciences Center, Denver 80262.

The amount of proteinuria is a prognostic indicator in a variety of glomerular disorders. To examine the importance of urinary protein excretion in autosomal dominant polycystic kidney disease, this study determined the clinical characteristics of autosomal dominant polycystic kidney disease patients with established proteinuria and the frequency of microalbuminuria in hypertensive autosomal dominant polycystic kidney disease patients without proteinuria. In 270 autosomal dominant polycystic kidney disease patients, mean 24-h urinary protein excretion was 259 +/- 22 mg/day. Forty-eight of 270 autosomal dominant poly-cystic kidney disease patients had over proteinuria (> 300 mg/day). The patients with established proteinuria had higher mean arterial pressures, larger renal volumes, and lower creatinine clearances than did their nonproteinuric counterparts (all P < 0.0001), a greater pack year smoking history (P < 0.05), and the projection of a more aggressive course of renal disease (P < 0.05). All autosomal dominant polycystic kidney disease patients with established proteinuria were hypertensive, as compared with 67% without established proteinuria (P < 0.001). Forty-nine patients with hypertension and left ventricular hypertrophy without established proteinuria were examined for microalbuminuria; 41% demonstrated microalbuminuria. Those with microalbuminuria had higher mean arterial pressure, larger renal volumes and increased filtration fraction. Therefore, established proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease patients are associated with increased mean arterial pressure and more severe renal cystic involvement.

This article has been cited by other articles:

				A. B. Chapman Approaches to Testing New Treatments in Autosomal Dominant Polycystic Kidney Disease: Insights from the CRISP and HALT-PKD Studies Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1197 - 1204. [Abstract] [Full Text] [PDF]

				R. Zeltner, R. Poliak, B. Stiasny, R. E. Schmieder, and B. D. Schulze Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease Nephrol. Dial. Transplant., February 1, 2008; 23(2): 573 - 579. [Abstract] [Full Text] [PDF]

				A. B. Chapman Autosomal Dominant Polycystic Kidney Disease: Time for a Change? J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1399 - 1407. [Abstract] [Full Text] [PDF]

				E. A. Jaimes, R.-X. Tian, and L. Raij Nicotine: the link between cigarette smoking and the progression of renal injury? Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H76 - H82. [Abstract] [Full Text] [PDF]

				J. J. Grantham, A. B. Chapman, and V. E. Torres Volume Progression in Autosomal Dominant Polycystic Kidney Disease: The Major Factor Determining Clinical Outcomes Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 148 - 157. [Abstract] [Full Text] [PDF]

				E. Ejerblad, C. M. Fored, P. Lindblad, J. Fryzek, P. W. Dickman, C.-G. Elinder, J. K. McLaughlin, and O. Nyren Association between Smoking and Chronic Renal Failure in a Nationwide Population-Based Case-Control Study J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2178 - 2185. [Abstract] [Full Text] [PDF]

				M. A. van Dijk, M. H. Breuning, R. Duiser, L. A. van Es, and R. G. J. Westendorp No effect of enalapril on progression in autosomal dominant polycystic kidney disease Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2314 - 2320. [Abstract] [Full Text] [PDF]

				M. K. Haroun, B. G. Jaar, S. C. Hoffman, G. W. Comstock, M. J. Klag, and J. Coresh Risk Factors for Chronic Kidney Disease: A Prospective Study of 23,534 Men and Women in Washington County, Maryland J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2934 - 2941. [Abstract] [Full Text] [PDF]

				S. R. Orth Smoking and the Kidney J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1663 - 1672. [Full Text] [PDF]

				N. Obermuller, B. Kranzlin, W. F. Blum, N. Gretz, and R. Witzgall An endocytosis defect as a possible cause of proteinuria in polycystic kidney disease Am J Physiol Renal Physiol, February 1, 2001; 280(2): F244 - F253. [Abstract] [Full Text] [PDF]

				T. ECDER and R. W. SCHRIER Hypertension in Autosomal-Dominant Polycystic Kidney Disease: Early Occurrence and Unique Aspects J. Am. Soc. Nephrol., January 1, 2001; 12(1): 194 - 200. [Full Text]

				J.-M. Halimi and A. Mimran Renal effects of smoking: potential mechanisms and perspectives Nephrol. Dial. Transplant., July 1, 2000; 15(7): 938 - 940. [Full Text] [PDF]

				M. A. VAN DIJK, D. J.M. PETERS, M. H. BREUNING, and P. C. CHANG The Angiotensin-Converting Enzyme Genotype and Microalbuminuria in Autosomal Dominant Polycystic Kidney Disease J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1916 - 1920. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673